We are committed to "providing today's patients with medicines of the future" across the following core therapeutic areas: oncology, central nervous system, autoimmunity, and infectious disease. Meanwhile, we are also actively expanding our presence in disease areas with significant unmet clinical needs in the future.

Qualifications:

• MD and/or Ph.D. in the biological sciences or related fields, with 6+ years of experience in Business Development

• Must have - Scientific or clinical expertise in Autoimmune, CNS, Inflammation, or related fields, including the drug development and commercialization process

• Highly Desirable – Scientific and/or BD&L experience in additional therapeutic areas; experience in Alliance Management

• Extensive experience in biotech or pharmaceutical R&D, demonstrating international experience in multiple cultures and drug discovery / clinical environments

• Demonstrated experience leading and influencing experienced professionals and executives

• Ability to think critically, creatively and to anticipate and solve problems

Responsibilities:

• The Senior - Executive Director of Business Development will play a key role in developing and executing the company’s overall business strategy

• Identify growth opportunities and areas of innovation

• Ability to make key decisions and quickly prioritize on most interesting partnering opportunities

• Proactively monitor the external business environment and maintain a knowledge base of licensing transactions

• Support the identification, evaluation, and execution of acquisition, investment, and partnership opportunities across the CNS or Autoimmune therapeutic area, and assets, including Out-licensing/in-licensing opportunities

• Support the drafting and negotiating of transaction term sheets utilizing creative deal structures and processes that result in business success and maximum value

• Actively involved in managing alliances and ensuring their highest chance of success

• Negotiation and structuring of licensing agreements and implementation of alliances

Posted On: Thursday, May 18, 2023